AED Plus and Fully Automatic AED Plus

Automated External Defibrillators (non-wearable)

FDA Premarket Approval P160015

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for the aed plus and fully automatic aed plus. These devices are indicated for use when a suspected cardiac arrest victim has an apparent lack of circulation as indicated by:1) unconsciousness;2) absence of normal breathing; and3) absence of a pulse or signs of circulationthese devices are intended for use by personnel who have been trained in their operation. Users should have received training in basic life support/aed, advanced life support or a physician-authorized emergency medical response training program. When a victim is less than 8 years of age, or weighs less than 55 lbs. (25kg), the zoll aed plus® and fully automatic aed plus® should be used with the zoll aed plus and fully automatic aed plus® pediatric electrodes. Therapy should not be delayed to determine the patients exact age or weight.

DeviceAED Plus and Fully Automatic AED Plus
Classification NameAutomated External Defibrillators (non-wearable)
Generic NameAutomated External Defibrillators (non-wearable)
ApplicantZOLL MEDICAL CORPORATION
Date Received2016-06-02
Decision Date2017-05-26
Notice Date2017-08-07
PMAP160015
SupplementS
Product CodeMKJ
Docket Number17M-3372
Advisory CommitteeCardiovascular
Expedited ReviewNo
Combination Product No
Applicant Address ZOLL MEDICAL CORPORATION 269 & 271 Mill Road chelmsford, MA 01824
Summary:Summary of Safety and Effectiveness
Labeling: Labeling
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P160015Original Filing
S014 2022-05-20 30-day Notice
S013 2022-02-23 30-day Notice
S012 2021-08-06 30-day Notice
S011 2021-02-24 30-day Notice
S010 2021-02-16 30-day Notice
S009 2020-12-18 30-day Notice
S008 2020-12-16 30-day Notice
S007 2020-12-15 30-day Notice
S006 2020-09-28 30-day Notice
S005
S004 2020-03-27 Normal 180 Day Track No User Fee
S003 2020-01-03 30-day Notice
S002 2018-08-23 135 Review Track For 30-day Notice
S001

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.